Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies

By L. Marelli, R. Stigliano, C. Triantos, M. Senzolo, E. Cholongitas, N. Davies, J. Tibballs, T. Meyer, D. Patch, Andrew K. Burroughs. Cardiovascular and Interventional Radiology, 2007

848 citations recorded by the source corpus.

Subfields: Hepatology, Surgery

View Paper: https://www.semanticscholar.org/paper/0569807b29692d3efb5833e0b1c34b05870523f5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hepatology

1. M. Kudo
2. A. Cheng
3. Riccardo Lencioni
4. J. Llovet
5. Jordi Bruix1 , 2

Citations in the corpus

• Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study (2009, background): “A further review failed to demonstrate either a survival difference between TACE and embolization alone or superiority of one chemotherapeutic agent over another [18].”
• Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma (2010, background): “The end point for the mixture administration is stasis in tumor-feeding arteries or appearance of lipiodol in portal vein branches near the tumor [321, 326, 327].”